Overview

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of the matrix fentanyl patch ZR-02-01 in providing relief of cancer pain.
Phase:
Phase 3
Details
Lead Sponsor:
ZARS Pharma Inc.
Treatments:
Fentanyl